The Institute of Global Health Innovation and the Department of Bioengineering are delighted to host a guest lecture by Professor Stephen Quake, one of the world’s most distinguished bioengineers.
In this talk, will draw on his pioneering work in microfluidics, genomics, and molecular diagnostics to explore how the genomic revolution is transforming clinical medicine through liquid biopsies and what that means for the future of disease detection and patient care.
About the speaker
Professor Stephen Quake is the Lee Otterson Professor of Bioengineering and Professor of Applied Physics at Stanford University and is co-President of the Chan Zuckerberg Biohub.
He received a B.S. in Physics and a M.S. in Mathematics from Stanford University in 1991 and a doctorate in Theoretical Physics from the University of Oxford in 1994.
Quake has invented many measurement tools for biology, including new DNA sequencing technologies that have enabled rapid analysis of the human genome and microfluidic automation that allows scientists to efficiently isolate individual cells and decipher their genetic code.
Quake is also well known for inventing new diagnostic tools, including the first non-invasive prenatal test for Down syndrome and other aneuploidies. His test is rapidly replacing risky invasive approaches such as amniocentesis, and millions of women each year now benefit from this approach.
His innovations have helped to radically accelerate the pace of biology and have made medicine safer by replacing invasive biopsies with simple blood tests.